Springbok Capital Management »

Altimmune shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $33k 13k 2.60
2020-09-30 $3.0k 200 15.00
2020-06-30 $2.0k 200 10.00

More positions owned by Springbok Capital Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Tesla Motors (TSLA)
Activision Blizzard Call Option
Horizon Therapeutics Pub L SHS Call Option
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Consol Energy (CEIX)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Brighthouse Finl (BHF)
Netease Sponsored Ads (NTES)
Bio Rad Labs Cl A (BIO)
Select Sector Spdr Tr Sbi Int-utils Put Option (XLU)
Trip Com Group Ads (TCOM)

View all positions for Springbok Capital Management

Top funds holding Altimmune

Vanguard Group
Tang Capital Management
Point72 Asset Management
Jane Street
Citadel Advisors
Goldman Sachs Group
Jacobs Levy Equity Management
Fred Alger Management
Kennedy Capital Management
Beirne Wealth Consulting Services
Wolverine Trading
D. E. Shaw & Co
Gerber
Dimensional Fund Advisors
GSA Capital Partners

View all funds holding Altimmune